Nawfal, R., Gulati, G. S., Vasseur, D., Sotudian, S., Semaan, K., Seo, J., Phillips, N., Canniff, J., Savignano, H., Trowbridge, R., Epstein, I. B., Rickards, G., Chehade, R. E. H., Zhang, Z., Lee, G. M., Bellmunt, J., Baca, S. C., Freedman, M. L., Choueiri, T. K. (2026). Use of
                    <i>NECTIN4</i>
                    expression inferred from circulating chromatin to predict response and survival to enfortumab vedotin (EV) in metastatic urothelial carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4588